Literature DB >> 6462028

[Distribution and excretion of [35S]NaHSO3-andrographolide by autoradiography (author's transl)].

S P Zhu, B A Kang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6462028

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


× No keyword cloud information.
  5 in total

1.  Engineered andrographolide nanoparticles mitigate paracetamol hepatotoxicity in mice.

Authors:  Partha Roy; Suvadra Das; Runa Ghosh Auddy; Achintya Saha; Arup Mukherjee
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

2.  Andrographolide nanoparticles in leishmaniasis: characterization and in vitro evaluations.

Authors:  Partha Roy; Suvadra Das; Tanmoy Bera; Subhasis Mondol; Arup Mukherjee
Journal:  Int J Nanomedicine       Date:  2010-12-09

3.  In vitro susceptibilities of wild and drug resistant leishmania donovani amastigote stages to andrographolide nanoparticle: role of vitamin E derivative TPGS for nanoparticle efficacy.

Authors:  Subhasish Mondal; Partha Roy; Suvadra Das; Asim Halder; Arup Mukherjee; Tanmoy Bera
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

4.  Engineered andrographolide nanosystems for smart recovery in hepatotoxic conditions.

Authors:  Partha Roy; Suvadra Das; Runa Ghosh Auddy; Arup Mukherjee
Journal:  Int J Nanomedicine       Date:  2014-10-09

5.  Designed Synthesis of Nanostructured Magnetic Hydroxyapatite Based Drug Nanocarrier for Anti-Cancer Drug Delivery toward the Treatment of Human Epidermoid Carcinoma.

Authors:  Bharath Govindan; Beeseti Swarna Latha; Ponpandian Nagamony; Faheem Ahmed; Muheet Alam Saifi; Abdel Halim Harrath; Saleh Alwasel; Lamjed Mansour; Edreese H Alsharaeh
Journal:  Nanomaterials (Basel)       Date:  2017-06-06       Impact factor: 5.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.